MicroRNAs in central nervous system diseases: A prospective role in regulating blood-brain barrier integrity

Feifei Ma1, Xuejing Zhang1, Ke-Jie Yin2

  • 1Pittsburgh Institute of Brain Disorders & Recovery, Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.

Experimental Neurology
|November 3, 2019
PubMed

Insights

MicroRNAs (miRNAs) are crucial for maintaining the blood-brain barrier (BBB) integrity, impacting central nervous system (CNS) homeostasis. Understanding cerebral miRNAs offers new therapeutic avenues for CNS disorders.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • The blood-brain barrier (BBB) is vital for central nervous system (CNS) function.
  • BBB dysfunction is implicated in various neurological diseases, including stroke, dementia, and infections.
  • MicroRNAs (miRNAs) are increasingly recognized for their role in cellular regulation.

Purpose of the Study:

  • To review the current understanding of how cerebral microRNAs (miRNAs) regulate blood-brain barrier (BBB) function.
  • To highlight the direct impact of miRNAs on the BBB's molecular composition.
  • To explore the therapeutic potential of miRNAs for CNS disorders.

Main Methods:

  • Literature review of recent studies on miRNAs and the BBB.
  • Analysis of research demonstrating miRNA involvement in BBB maintenance and CNS homeostasis.
  • Synthesis of evidence on miRNA regulation of BBB molecular components.

Main Results:

  • Cerebral miRNAs play a direct role in maintaining the BBB's structural and functional integrity.
  • Dysregulation of specific miRNAs is linked to BBB breakdown in CNS diseases.
  • miRNAs influence the BBB's molecular composition, affecting its permeability and transport functions.

Conclusions:

  • Cerebral miRNAs are key regulators of blood-brain barrier (BBB) function in the central nervous system (CNS).
  • Targeting miRNAs presents a promising strategy for developing novel therapies for CNS diseases characterized by BBB disruption.
  • Further research into miRNA-BBB interactions will deepen our understanding of neurological disease pathogenesis.